Mortality from tuberculosis and HIV infection in the Kaluga region before and during the COVID-19 pandemic

Abstract

The COVID-19 pandemic has impacted the timeliness of diagnostic measures for a number of infectious diseases, which has affected the timing of diagnosis and the dynamics of the mortality rate.

The aim of the study was to investigate the dynamics of mortality in the Kaluga region before and during the COVID-19 pandemic.

Material and methods. A retrospective epidemiological analysis of mortality for 2012–2021 was carried out in the Kaluga region. The study included data on 2261 adult patients with respiratory tuberculosis (TB). In 104 cases, TB was diagnosed posthumously and in 2157 cases – intravital. Information from federal statistical observation forms No. 8 and 33 and Rosstat data on population for 2012–2021 were used. The results were processed using variation statistics methods. Statistical analysis was carried out using the StatTech v.3.0.6 program. Extensive indicators were calculated. Differences were considered statistically significant at p<0.05.

Results and discussion. In the Kaluga region, during the COVID-19 pandemic, an increase in mortality from TB was detected due to a significant increase in the proportion of patients in whom TB was diagnosed posthumously, most often among the unemployed. During the analyzed period, despite a significant increase in the proportion of HIV-infected people receiving antiretroviral therapy, there was an increase in the mortality rate from HIV infection (up to 4.1 per 100 thousand population in 2021).

Conclusion. Before the COVID-19 pandemic, there was a downward trend in mortality from TB in the Kaluga region. During the pandemic, TB screening rates have decreased, leading to an increase in the number of TB patients. An increase in the proportion of patients with a posthumous diagnosis of TB was noted. Mortality from HIV infection has increased before the pandemic, and this trend continued during the pandemic.

Keywords:COVID-19 pandemic; mortality from tuberculosis and HIV infection; screening; post-mortem diagnosis of tuberculosis; groups at increased risk of tuberculosis

Funding. The study had no sponsorship.

Conflict of interest. The authors declare no conflict of interest.

Contribution. The concept and design of the study – Lapshina I.S., Tsybikova E.B.; collecting and processing materials – Lapshina I.S., Tsybikova E.B.; statistical processing – Lapshina I.S.; writing the text – Tsybikova E.B., Lapshina I.S.; editing – Tsybikova E.B.

For citation: Lapshina I.S., Tsybikova E.B. Mortality from tuberculosis and HIV infection in the Kaluga region before and during the COVID-19 pandemic. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2024; 13 (1): 20–6. DOI: https://doi.org/10.33029/2305-3496-2024-13-1-20-26 (in Russian)

References

1. WHO Global TB Report 2021. Geneva, 2021. URL: https://the-union.org/news/the-union-statement-on-who-global-tub-report-2021

2. Restored E., Shaker B.S., Naqibullah M., et al. Chest X-ray findings in tuberculosis patients identified by passive and active case finding: a retrospective study. J Clin Tuberc Other Mycobact Dis. 2019; 14: 26–30. DOI: https://doi.org/10.1016/j.jctube.2019.01.003

3. Gupta R.K., Lule S.A., Krutikov M., et al. Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study. Eur Respir J. 2021; 57: 2003831. DOI: https://doi.org/10.1183/13993003.03831-2020

4. Michalowsky B., Hoffmann W., Bohlken J., Kostev K. Effect of COVID-19 lockdown on disease recognition and utilization of healthcare services in the older population in Germany: a cross-sectional study. Age Ageing. 2021; 50: 317–25. DOI: https://doi.org/10.1093/ageing/afaa260

5. Gao Y., Liu M., Chen Y., Shi S., Geng J., Tian J. Association between tuberculosis and COVID-19 severity and mortality: a rapid systematic review and meta-analysis. J Med Virol. 2021; 93 (1): 194–6. DOI: https://doi.org/10.1002/jmv.26311

6. Dowdy D.W. Has the COVID-19 pandemic increased tuberculosis mortality? Lancet Infect Dis. 2022; 22 (2): 165–66. DOI: https://doi.org/10.1016/S1473-3099(22)00006-8

7. Cilloni L., Fu H., Vesga J.F., Dowdy D., Pretorius C., Ahmedov S., et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020; 28 (10): 100603. DOI: https://doi.org/10.1016/j.eclinm.2020.100603 PMID: 33134905

8. Saunders M.J, Evans C.A. COVID-19, tuberculosis and poverty: preventing a perfect storm. Eur Respir J. 2020; 56 (1): 2001348. DOI: https://doi.org/10.1183/13993003.01348-2020

9. Collection of examples of best health practices in the field of combating HIV infection in the WHO European Region. Copenhagen: WHO Regional Office for Europe, 2018. URL: https://www.euro.who.int/ru/publications/abstracts/compendium-of-good-practices-in-the-health-sector-response-to-hiv-in-the-who-european-region (in Russian)

10. Abdool Karim Q., Baxter C. COVID-19: impact on the HIV and tuberculosis response, service delivery, and research in South Africa. Curr HIV/AIDS Rep. 2022; 19 (1): 46–53.

11. International Statistical Classification of Diseases and health-related problems. The tenth revision. Vol. 2. Collection of instructions. Geneva: WHO, 1995: 179 p. (in Russian)

12. Lapshina I.S., Tsybikova E.B., Kotlovsky M.Yu. Risk groups of respiratory tuberculosis among the adult population of the Kaluga region. Tuberkulez i bolezni legkikh [Tuberculosis and Lung Diseases]. 2022; 100 (11): 20–8. DOI: https://doi.org/10.21292/2075-1230-2022-100-11-20-28 (in Russian)

13. Dheda K., Perumal T., Moultrie H., et al. The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions. Lancet Respir Med. 2022; 10 (6): 603–22. DOI: https://doi.org/10.1016/S2213-2600(22)00092-3

14. Astrelin A.M. Trends in incidence, prevalence and mortality from HIV infection and tuberculosis in Russian regions in the 21st century. Demograficheskoe obozrenie [Demographic Overview]. 2020; 7 (4): 82–107. DOI: https://doi.org/10.17323/demreview.v7i4.12045 (in Russian)

15. Guseynalieva V.N. Improving the detection of tuberculosis in primary health care institutions and its impact on the incidence rate. Tuberkulez i bolezni legkikh [Tuberculosis and Lung Diseases]. 2020; 98 (10): 41–6. DOI: https://doi.org/10.21292/2075-1230-2020-98-10-41-46 (in Russian)

16. Borodulina E.V., Borodulina E.A., Gladunova E.P., et al. Medical and social characteristics of newly diagnosed patients with tuberculosis. Meditsinskiy al’yans [Medical Alliance]. 2018; (3): 41–6. (in Russian)

17. Azovtseva O.V., Trofimova T.S., Arkhipov G.S., et al. Deaths in patients with HIV infection, parallels with the adequacy of diagnosis, medical examination and treatment. VICH infektsiya i immunosupressii [HIV Infection and Immunosuppression]. 2018; 10 (3): 90–101. (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
Aleksandr V. Gorelov
Academician of the Russian Academy of Sciences, MD, Head of Infection Diseases and Epidemiology Department of the Scientific and Educational Institute of Clinical Medicine named after N.A. Semashko ofRussian University of Medicine, Ministry of Health of the Russian Federation, Professor of the Department of Childhood Diseases, Clinical Institute of Children's Health named after N.F. Filatov, Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Deputy Director for Research, Central Research Institute of Epidemiology, Rospotrebnadzor (Moscow, Russian Federation)

Journals of «GEOTAR-Media»